Dudley Robert Michael 13D/13G Filings for TransCode Therapeutics, Inc. (RNAZ)

Dudley Robert Michael 13D and 13G filings for TransCode Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-10-10
4:00 pm
Purchase
2023-09-2813DTransCode Therapeutics, Inc.
RNAZ
Dudley Robert Michael6
1.900%
3increase
(+104.19%)
Filing
2023-06-16
4:00 pm
Purchase
2023-06-0913DTransCode Therapeutics, Inc.
RNAZ
Dudley Robert Michael3
6.000%
3increase
(New Position)
Filing